Action Voyager Acquisition - VACH

Voyager Acquisition Corporation (VACH) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

10,60

( - )

Prix Achat

4,31

Prix Vente

15,00

Volume échangé

6 279

10,60 Fourchette du Jour 10,60

8,40 Plage de 52 semaines 15,68

Cap du marché

67,921M

Clôture Veille

10,60

Ouverture

10,60

Dernière Transaction

9.78

Dernière heure de transaction

Volume financier

US$ 66 557

VWAP

10,60

Volume moyen (3 m)

US$ 18 319

Actions en circulation

6 407 685

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

43,22

Bénéfice par action (BPA)

0,22

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

6,74M

Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthc... Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. Voyager Acquisition Corp. was incorporated in 2023 and is based in Brooklyn, New York. Show more

Secteur

Industrie

Site Web

www.voyageracq.com

Siège social

Brooklyn, United States

Fondé

2026

Voyager Acquisition Corporation est coté dans le secteur de la NASDAQ avec le ticker VACH. Le dernier cours de clôture d'Voyager Acquisition était de US$10,60. Au cours de la dernière année, les actions de Voyager Acquisition ont été négociées dans une fourchette de prix de US$ 8,40 à US$ 15,68.

Voyager Acquisition compte actuellement 6 407 685 actions en circulation. La capitalisation boursière d'Voyager Acquisition est de US$67,92 million. Voyager Acquisition a un ratio cours/bénéfice (ratio PE) de 43.22.

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the...

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the...

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies...

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

ZURICH, May 29, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed...

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

ZURICH, May 20, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel...

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 05, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and...

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

VERAXA’s Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug...

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

BROOKLYN, N.Y., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) announced that holders of the units...

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

BROOKLYN, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) today announced that it closed its...

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

BROOKLYN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) announced today the pricing of its...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.5	4.9504950495	10.1	11.2	9	7732	10.26329815	CS
4	-2.15	-16.862745098	12.75	13.4775	8.4	8876	10.6698915	CS
12	-0.45	-4.07239819005	11.05	15.68	8.4	14560	11.69908332	CS
26	0.06	0.569259962049	10.54	15.68	8.4	87792	10.75439834	CS
52	0.21	2.02117420597	10.39	15.68	8.4	55892	10.6761767	CS
156	0.64	6.42570281124	9.96	15.68	8.4	73637	10.35027152	CS
260	0.64	6.42570281124	9.96	15.68	8.4	73637	10.35027152	CS

VACH - Frequently Asked Questions (FAQ)

What is the current Voyager Acquisition Corporation share price?

The current share price of Voyager Acquisition Corporation is US$ 10,60

How many Voyager Acquisition Corporation shares are in issue?

Voyager Acquisition Corporation has 6 407 685 shares in issue

What is the market cap of Voyager Acquisition Corporation?

The market capitalisation of Voyager Acquisition Corporation is USD 67,92M

What is the 1 year trading range for Voyager Acquisition Corporation share price?

Voyager Acquisition Corporation has traded in the range of US$ 8,40 to US$ 15,68 during the past year

What is the PE ratio of Voyager Acquisition Corporation?

The price to earnings ratio of Voyager Acquisition Corporation is 43,22

What is the registered address of Voyager Acquisition Corporation?

The registered address for Voyager Acquisition Corporation is 131 Concord Street, Brooklyn, New York, 11201

What is the Voyager Acquisition Corporation website address?

The website address for Voyager Acquisition Corporation is www.voyageracq.com

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Voyager Acquisition Corporation (VACH)

Voyager Acquisition Corporation (VACH) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Voyager Acquisition Corporation

VACH Dernières nouvelles

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

VACH - Frequently Asked Questions (FAQ)

VACH Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Voyager Acquisition Corporation (VACH)

Voyager Acquisition Corporation (VACH) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Voyager Acquisition Corporation

VACH Dernières nouvelles

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

VACH - Frequently Asked Questions (FAQ)

VACH Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités